Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1990-11-14
1993-05-04
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
5303881, 5303911, 5303913, 5303915, 5303917, 5303919, 424 9, 424 8591, 435 71, 436512, A61K 4902, C07K 1528, C07K 1502
Patent
active
052080080
ABSTRACT:
A method of selectively modifying an immunoglobulin having at least one Fab region and at least one Fc region, each region having an isoelectric point wherein said isoelectric point of the Fab fragment of said immunoglobulin is different than the isoelectric point of the Fc fragment of the immunoglobulin, said method comprising modification of the immunoglobulin at a pH between the respective isoelectric points of the Fab and Fc fragments of the immunoglobulin.
REFERENCES:
patent: 4671958 (1987-06-01), Rodwell et al.
Nanda et al. (1989) J. Neurosurg. 71:892-897.
Ahmad et al. (1988) Trends in Biotech. 6:246-251.
Blair et al. (1983) J. Immunol. Methods 59:129-143.
Dictionary of Immunology, W. Herbert et al., eds., Blackwell Scientific Publications 1985, Oxford, pp. 80-81.
Ghose et al. (1983) Methods Enzymol. 93:280-333.
Simonson et al. (1988) Clin. Chem. 34/9:1713-1716.
Bloomer William
Epperly Michael
Ranadive Girish
Rosenzweig Howard S.
Kim Kay K.
Nucker Christine M.
University of Pittsburgh
LandOfFree
Regioselective chemical modification of monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regioselective chemical modification of monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regioselective chemical modification of monoclonal antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1973700